Compare Novavax Inc (NVAX) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Wendys Co — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Wendys Co trades at $7.62 (market cap $1.50B). The key difference: Wendys Co is the larger of the two by market cap, and Wendys Co pays a 7.13% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WEN | |
|---|---|---|
Market Cap | $1.30B | $1.50B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $11.33 |
52-Week Low | $6.22 | $6.17 |
Enterprise Value | $800.50M | $5.31B |
Dividend Yield | — | 7.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
